EPIVAX THERAPEUTICS

EpiVax Therapeutics ('EVT'), an emerging biotechnology startup founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body's T cells to cure or prevent disease in the host... Provide personalized cancer immunotherapy that is safe, effective, and broadly applicable

Also known as: EpiVax Therapeutics, Inc.

Primary location: Providence United States